<DOC>
	<DOCNO>NCT01873872</DOCNO>
	<brief_summary>We design study measure effect normal flora supplementation , use available probiotic , incidence Clostridium difficile-associated diarrhea population general inpatient receive antibiotic .</brief_summary>
	<brief_title>Evaluation Probiotics Development Clostridium Difficile Associated Diarrhea Patients Receiving Antibiotics</brief_title>
	<detailed_description>General medical-surgical patient community hospital receive antibiotic , agree participate , give one two different probiotic , placebo . Data gather hospitalization , one three month follow hospital discharge . We expect see low incidence Clostridium difficile-associated diarrhea probiotic group compare placebo group . We also look difference effect two probiotic , differ strain type number colony form unit per dose .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Any hospitalized patient age 19 old receiving antibiotic . Feeding tube place Pregnancy Milk soy allergy Sensitivity lactose Immunocompromised define : 1 . Absolute neutrophil count ( ANC ) â‰¤ 500 cells/mm3 2 . HIV 3 . Cancer patient receive chemotherapy radiation therapy 4 . Immune deficiency 5 . Post organ transplant Participants withdraw study develop exclusion criterion hospitalization .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>